Cargando…

Erratum to “Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanoma”

Detalles Bibliográficos
Autores principales:	Ponti, Giovanni, Pellacani, Giovanni, Tomasi, Aldo, Loschi, Pietro, Luppi, Gabriele, Gelsomino, Fabio, Longo, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058163/ http://dx.doi.org/10.1155/2014/246751

Ejemplares similares

Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas
por: Giovanni, Ponti, et al.
Publicado: (2014)

Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma
por: Ponti, Giovanni, et al.
Publicado: (2012)

Erratum: Clinical responses to ERK inhibition in BRAF(V600E)-mutant colorectal cancer predicted using a computational model
por: Kirouac, Daniel C., et al.
Publicado: (2017)

BRAF(V600E) Immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells: A STROBE-Compliant Article: Erratum
Publicado: (2015)

BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi
por: Francis, Jasmine H., et al.
Publicado: (2018)

BRAF, NRAS, KIT, TERT, GNAQ/GNA11 Mutation Profile and Histomorphological Analysis of Anorectal Melanomas: A Clinicopathologic Study
por: Taskın, Orhun Cig, et al.
Publicado: (2023)

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations
por: Goldinger, Simone M., et al.
Publicado: (2013)

BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS
por: Röck, Ruth, et al.
Publicado: (2019)

Erratum to “Evaluation of the Expression of C-Kit (CD117) in Ependymomas and Oligodendrogliomas”
por: Zavalhia, Lisiane Silveira, et al.
Publicado: (2014)

Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
por: Huang, Zheyong, et al.
Publicado: (2020)

COMP: A Potential Early Biomarker of RAS After Lung Transplantation: Erratum
Publicado: (2022)

Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature
por: Manfredi, Andreina, et al.
Publicado: (2020)

Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
por: Nannini, Margherita, et al.
Publicado: (2017)

BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low-grade glioma
por: Laviv, Yosef, et al.
Publicado: (2012)

Erratum: Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species
por: Manent, J, et al.
Publicado: (2017)

Proteomic Analysis of PTCH1+/− Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients
por: Ponti, Giovanni, et al.
Publicado: (2013)

Reliability of BRAF mutation detection using plasma sample: A protocol for systematic review and meta-analysis: Erratum
Publicado: (2022)

GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
por: Pópulo, Helena, et al.
Publicado: (2013)

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
por: Wong, Deborah JL, et al.
Publicado: (2015)

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
por: Banzi, Maria, et al.
Publicado: (2016)

Erratum to: The Chemistry Development Kit (CDK) v2.0: atom typing, depiction, molecular formulas, and substructure searching
por: Willighagen, Egon L., et al.
Publicado: (2017)

Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome
por: Ponti, Giovanni, et al.
Publicado: (2012)

Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report
por: Zelli, Veronica, et al.
Publicado: (2022)

Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis
por: Emelyanova, Marina, et al.
Publicado: (2017)

Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome
por: Pastorino, Lorenza, et al.
Publicado: (2012)

Erratum to “Hand Surgery Patient Perspectives on Medical Cannabis: A Survey of Over 600 Patients” [Journal of Hand Surgery Global Online 5 (2023) 102-107]
por: Fones, Lilah, et al.
Publicado: (2023)

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries
por: Pipek, Orsolya, et al.
Publicado: (2023)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
por: Gelsomino, Francesco, et al.
Publicado: (2021)

Erratum for Rued et al., “Quorum Sensing in Streptococcus mutans Regulates Production of Tryglysin, a Novel RaS-RiPP Antimicrobial Compound”
por: Rued, Britta E., et al.
Publicado: (2021)

Erratum to: Consensus classification of human leukocyte antigen class II proteins
por: Saha, Indrajit, et al.
Publicado: (2013)

Misaligned sequencing reads from the GNAQ-pseudogene locus may yield GNAQ artefact variants
por: Lim, Jing Quan, et al.
Publicado: (2022)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Immunohistochemical mismatch repair proteins expression as a tool to predict the melanoma immunotherapy response
por: Ponti, Giovanni, et al.
Publicado: (2020)

Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19
por: Ponti, Giovanni, et al.
Publicado: (2020)

Erratum: Tailoring superradiance to design artificial quantum systems
por: Longo, Paolo, et al.
Publicado: (2016)

Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma
por: Nepote, Alessandro, et al.
Publicado: (2022)

Mutational Profile of GNAQ (Q209) in Human Tumors
por: Lamba, Simona, et al.
Publicado: (2009)

Erratum to: Surgical evolution in the treatment of mandibular condyle fractures
por: Belli, Evaristo, et al.
Publicado: (2015)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0gvekmf870elflvacselavpid7